Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine

Acta Pharmacol Sin. 2015 Jun;36(6):651-3. doi: 10.1038/aps.2015.33.

Authors

Dayue Darrel Duan¹, Zhong Wang², Bo-li Zhang³, Yong-yan Wang²

Affiliations

¹ Laboratory of Cardiovascular Phenomics, Department of Pharmacology, Center for Molecular Medicine, University of Nevada School of Medicine, Reno, Nevada 89557, USA.
² Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
³ Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Computational Biology / methods*
Drug Combinations
Drug Synergism
Drugs, Chinese Herbal / adverse effects
Drugs, Chinese Herbal / therapeutic use*
Humans
Medicine, Chinese Traditional / methods*
Patient Selection
Phenotype
Precision Medicine / methods*
Systems Biology
Systems Integration
Treatment Outcome

Substances

Drug Combinations
Drugs, Chinese Herbal

Grants and funding

R01 HL113598/HL/NHLBI NIH HHS/United States